Verrica Pharmaceuticals
$14.579876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$14.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.07 (-0.48%) As of 2:21 PM EST today
-$0.07 (-0.48%) Today
Why Robinhood?
You can buy or sell VRCA and other stocks, options, ETFs, and crypto commission-free!
About VRCA
Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product VP-102, is a proprietary topical therapy used in common skin indications including Molluscum contagiosum and Verruca Vulgaris. Read More The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
CEO
Employees
16
Headquarters
West Chester, Pennsylvania
Founded
2013
Market Cap
384.05M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
42.95K
High Today
$14.77
Low Today
$14.36
Open Price
$14.68
Volume
20.56K
52 Week High
$18.67
52 Week Low
$6.84
Collections
VRCA Earnings
-$0.30
-$0.20
-$0.10
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 5, After Hours
People Also Bought
Viking Therapeutics
38,964
$6.90
-0.86%Myovant Sciences
5,601
$11.40
+2.01%Revance Therapeutics
1,484
$27.67
+0.33%Precision BioSciences
5,190
$8.06
0.00%Neptune Wellness
27,123
$1.80
-2.97%Catalyst Pharmaceuticals
52,477
$5.20
0.00%Aurora Cannabis
671,428
$1.65
-1.51%Corbus Pharmaceuticals
49,073
$5.59
-1.50%AnaptysBio
1,625
$16.15
+0.62%ViewRay
7,447
$3.39
+1.65%Evolent Health
3,199
$11.70
+0.52%Hexo
166,615